EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells

Yuqi Zhou, Julie Jadlowsky, Caitlin Baiduc, Alex W Klattenhoff, Zhilin Chen, Alan D Bennett, Nicholas J Pumphrey, Bent K Jakobsen, James L Riley iD

PLOS Pathogens · 2023

DOI: 10.1371/journal.ppat.1011853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Yuqi Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvan…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, HIV-1, HIV Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered T cells hold great promise to become part of an effective HIV cure strategy, but it is currently unclear how best to redirect T cells to target HIV. To gain insight, we generated engineered T cells using lentiviral vectors encoding one of three distinct HIV-specific T cell receptors (TCRs) or a previously optimized HIV-targeting chimeric antigen receptor (CAR) and compared their functional capabilities. All engineered T cells had robust, antigen-specific polyfunctional cytokine profiles when mixed with artificial antigen-presenting cells. However, only the CAR T cells could potently control HIV replication. TCR affinity enhancement did not augment HIV control but did allow TCR T cells to recognize common HIV escape variants. Interestingly, either altering Nef activity or adding additional target epitopes into the HIV genome bolstered TCR T cell anti-HIV activity, but CAR T cells remained superior in their ability to control HIV replication. To better understand why CAR T cells control HIV replication better than TCR T cells, we performed a time course to determine when HIV-specific T cells were first able to activate Caspase 3 in HIV-infected targets. We demonstrated that CAR T cells recognized and killed HIV-infected targets more rapidly than TCR T cells, which correlates with their ability to control HIV replication. These studies suggest that the speed of target recognition and killing is a key determinant of whether engineered T cell therapies will be effective against infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenHIV-1HIV InfectionsHumansReceptors, Antigen, T-CellVirus Replication

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Adaptimmune Ltd, Abingdon, United Kingdom.
  • Immunocore Ltd., Abingdon, United Kingdom.

ORCID-Profile: James L Riley

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Adaptimmune

Zitieren

APA

Zhou, Y., Jadlowsky, J., Baiduc, C., Klattenhoff, A. W., Chen, Z., Bennett, A. D., Pumphrey, N. J., Jakobsen, B. K., & Riley, J. L. (2023). Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011853

Vancouver

Zhou Y, Jadlowsky J, Baiduc C, Klattenhoff AW, Chen Z, Bennett AD, et al. Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011853

BibTeX
@article{Zhou2023,
  author = {Zhou, Yuqi and Jadlowsky, Julie and Baiduc, Caitlin and Klattenhoff, Alex W and Chen, Zhilin and Bennett, Alan D and Pumphrey, Nicholas J and Jakobsen, Bent K and Riley, James L},
  title = {Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells},
  journal = {PLOS Pathogens},
  year = {2023},
  doi = {10.1371/journal.ppat.1011853}
}
Kostenlos starten →